References

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study

10.1016/s0140-6736(02)08024-8 · 2002 · External reference

Effect of perindopril on physical function in elderly people with functional impairment: a randomized control trial

10.1503/cmaj.061339 · 2007 · External reference

ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study

10.1016/j.jamda.2009.09.014 · 2010 · External reference

The effect of perindopril on postural instability in older people with a history of falls—a randomised controlled trial

10.1093/ageing/afx127 · 2018 · External reference

A systematic Review and meta-analyses of the association between anti-hypertensive classes and the risk of falls among older adults

10.1007/s40266-018-0561-3 · 2018 · External reference

Danish register-based study on the association between specific cardiovascular drugs and fragility fractures

10.1136/bmjopen-2015-009522 · 2015 · External reference

Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study

10.1097/01.hjh.0000203845.26690.cb · 2006 · External reference

Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly

10.1002/jbmr.2271 · 2014 · External reference

ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men

2017 · External reference

Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study

10.1186/s12877-015-0154-5 · 2015 · External reference

Long-term effects of antihypertensive drug use and new-onset osteoporotic fracture in elderly patients: a population-based longitudinal cohort study

10.4103/0366-6999.195472 · 2016 · External reference

Risk of fractures in older adults using antihypertensive medication

10.1002/jbmr.356 · 2011 · External reference

ACE inhibitors and the risk of fractures: a meta-analysis of observational studies

10.1007/s12020-016-1201-5 · 2017 · External reference

Association between allopurinol use and hip fracture in older patients

10.1016/j.bone.2016.01.003 · 2016 · External reference

A proportional hazards model for the subdistribution of a competing risk

10.1080/01621459.1999.10474144 · 1999 · External reference

The effect of treatment based on a diuretic (indapamide) ± ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET)

10.1093/ageing/afq071 · 2010 · External reference

The impact of antihypertensive medications on bone mineral density and fracture risk

10.1007/s11886-017-0888-0 · 2017 · External reference

The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative

10.1007/s00198-019-05041-3 · 2019 · External reference

New Horizons in orthostatic hypotension

2017 · External reference

Effects of antihypertensive treatment on endothelial function

10.1007/s11906-011-0207-x · 2011 · External reference

Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

10.1016/j.jash.2013.09.001 · 2014 · External reference

Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study

10.1007/s00198-015-3332-6 · 2016 · External reference

Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men

10.1007/s11657-017-0387-3 · 2017 · External reference